Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Dec 31, 2025 → Mar 31, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| AstraZeneca PLC ORD USD0.25 | 0 | 11,232 | 11,232 | 5.62% | $2.22M |
| CELLDEX THERAPEUTICS INC | 0 | 12,614 | 12,614 | 1.02% | $400.12K |
| Abivax SA SPONSORED ADS | 0 | 3,424 | 3,424 | 0.97% | $381.26K |
| SPYRE THERAPEUTICS INC | 0 | 6,634 | 6,634 | 0.85% | $334.62K |
| VERACYTE INC | 0 | 6,838 | 6,838 | 0.56% | $220.25K |
| MONTE ROSA THERAPEUTICS INC | 0 | 12,566 | 12,566 | 0.52% | $206.71K |
| CANDEL THERAPEUTICS INC | 0 | 36,313 | 36,313 | 0.45% | $177.93K |
| ATRIUM THERAPEUTICS INC | 0 | 13,286 | 13,286 | 0.45% | $177.63K |
| AVALO THERAPEUTICS INC | 0 | 11,668 | 11,668 | 0.44% | $174.20K |
| ANNEXON INC | 0 | 24,518 | 24,518 | 0.34% | $135.83K |
| Alkermes PLC | 0 | 39,859 | 39,859 | 0.00% | $0 |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| ASTRAZENECA PLC SPONS ADR | 21,243 | 0 | -21,243 | 0.00% | -$1.95M |
| AVADEL PHARMACEU | 37,693 | 0 | -37,693 | 0.00% | -$812.28K |
| EXACT SCIENCES CORP | 7,901 | 0 | -7,901 | 0.00% | -$802.43K |
| AVIDITY BIOSCIENCES | 6,995 | 0 | -6,995 | 0.00% | -$504.55K |
| SCHOLAR ROCK HOLDING CORP | 9,974 | 0 | -9,974 | 0.00% | -$439.35K |
| DAY ONE BIOPHARMACEUTICALS INC | 26,812 | 0 | -26,812 | 0.00% | -$249.89K |
| ARBUTUS BIOPHARMA CORP | 47,925 | 0 | -47,925 | 0.00% | -$230.52K |
| ARTIVION INC | 4,015 | 0 | -4,015 | 0.00% | -$183.12K |
| BLACK DIAMOND THERAPEUTICS INC | 53,625 | 0 | -53,625 | 0.00% | -$130.31K |
| MONEYMKT | 2 | 0 | -2 | 0.00% | -$2 |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| FIRST AM-TR OB-X | 2,412,797 | 3,035,293 | 622,496 | 7.71% | $622.50K |
| VERTEX PHARMACEUTICALS INC | 4,663 | 4,931 | 268 | 5.59% | $87.87K |
| IONIS PHARMACEUTICALS INC | 18,523 | 19,587 | 1,064 | 3.73% | $5.43K |
| INSMED INC | 7,588 | 8,583 | 995 | 3.56% | $82.88K |
| INCYTE CORP | 13,471 | 14,245 | 774 | 3.40% | $10.21K |
| ROIVANT SCIENCES | 45,076 | 47,667 | 2,591 | 3.35% | $342.23K |
| ARGENX SE SPONSORED ADR | 1,425 | 1,794 | 369 | 3.33% | $111.71K |
| NEUROCRINE BIOSCIENCES INC | 7,383 | 9,607 | 2,224 | 3.21% | $218.50K |
| AXSOME THERAPEUTICS INC | 6,088 | 6,438 | 350 | 2.76% | -$23.76K |
| Ascendis Pharma A/S | 3,238 | 4,526 | 1,288 | 2.63% | $344.76K |
| APOGEE THERAPEUTICS INC | 10,751 | 11,369 | 618 | 2.43% | $145.44K |
| PROTAGONIST THERAPEUTICS INC | 8,549 | 9,040 | 491 | 2.42% | $206.15K |
| AMGEN INC | 2,202 | 2,329 | 127 | 2.08% | $98.72K |
| RHYTHM PHARMACEUTICALS INC | 5,052 | 9,297 | 4,245 | 2.05% | $267.79K |
| ABBVIE INC | 2,979 | 3,544 | 565 | 1.96% | $90.11K |
| BIOGEN INC | 3,627 | 3,835 | 208 | 1.79% | $64.75K |
| SANOFI SPON ADR | 13,594 | 14,382 | 788 | 1.76% | $34.16K |
| JAZZ PHARMACEUTI | 3,368 | 3,561 | 193 | 1.71% | $100.65K |
| CATALYST PHARMACEUTICALS INC | 22,020 | 23,286 | 1,266 | 1.46% | $62.61K |
| ORUKA THERAPEUTICS INC | 10,880 | 11,506 | 626 | 1.43% | $234.60K |
| BIONTECH SE ADR | 5,311 | 5,616 | 305 | 1.27% | -$6.46K |
| KRYSTAL BIOTECH INC | 1,813 | 1,918 | 105 | 1.26% | $48.48K |
| EDGEWISE THERAPEUTICS INC | 14,703 | 15,615 | 912 | 1.25% | $127.02K |
| NUVALENT INC-A | 4,404 | 4,657 | 253 | 1.21% | $34.11K |
| AGIOS PHARMACEUTICALS INC | 13,141 | 13,971 | 830 | 1.20% | $114.94K |
| NEWAMSTERDAM PHARMA CO NV COMMON STOCK | 13,731 | 14,656 | 925 | 1.19% | -$12.54K |
| MEIRAGTX HOLDINGS PLC COMMON STOCK USD.00001 | 28,496 | 53,694 | 25,198 | 1.18% | $238.45K |
| ALNYLAM PHARMACEUTICALS INC | 1,295 | 1,370 | 75 | 1.15% | -$61.66K |
| KYMERA THERAPEUTICS INC | 5,035 | 5,342 | 307 | 1.13% | $53.16K |
| PERSONALIS INC | 47,796 | 64,032 | 16,236 | 1.04% | $27.43K |
| NURIX THERAPEUTICS INC | 18,134 | 25,571 | 7,437 | 1.01% | $52.35K |
| CYTOKINETICS INC | 5,311 | 5,616 | 305 | 0.94% | $32.69K |
| HALOZYME THERAPEUTICS INC | 4,533 | 4,794 | 261 | 0.79% | $4.77K |
| CULLINAN THERAPE | 19,041 | 20,135 | 1,094 | 0.73% | $89.04K |
| TREVI THERAPEUTICS INC | 22,667 | 23,970 | 1,303 | 0.73% | $2.17K |
| NATERA INC | 1,295 | 1,370 | 75 | 0.70% | -$22.69K |
| XERIS BIOPHARMA HOLDINGS INC | 43,392 | 45,886 | 2,494 | 0.68% | -$74.49K |
| DISC MEDICINE INC | 3,756 | 3,972 | 216 | 0.64% | -$44.29K |
| DESIGN THERAPEUTICS INC | 20,262 | 21,231 | 969 | 0.57% | $35.84K |
| REZOLUTE INC | 67,056 | 71,227 | 4,171 | 0.55% | $58.99K |
| TECTONIC THERAPEUTIC INC | 6,476 | 6,849 | 373 | 0.54% | $76.61K |
| Wave Life Sciences Ltd. COM NPV | 27,590 | 29,175 | 1,585 | 0.54% | -$257.51K |
| RAPPORT THERAPEUTICS INC | 6,030 | 6,438 | 408 | 0.51% | $18.49K |
| SIONNA THERAPEUTICS INC | 2,720 | 4,818 | 2,098 | 0.49% | $81.25K |
| INTELLIA THERAPEUTICS INC | 10,880 | 11,506 | 626 | 0.37% | $49.70K |
| IQVIA HOLDINGS INC | 777 | 822 | 45 | 0.36% | -$34.96K |
| ARVINAS INC | 12,435 | 13,150 | 715 | 0.35% | -$8.09K |
| ALDEYRA THERAPEUTICS INC | 34,912 | 37,120 | 2,208 | 0.16% | -$118.11K |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| GILEAD SCIENCES INC | 21,761 | 20,260 | -1,501 | 7.17% | $152.69K |
| ICON PLC | 1,295 | 973 | -322 | 0.27% | -$128.30K |
| ADMA BIOLOGICS INC | 18,782 | 10,037 | -8,745 | 0.23% | -$252.15K |
| MDXHEALTH SA | 75,126 | 32,951 | -42,175 | 0.19% | -$192.41K |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.